Lepu Scientech Medical Technology (Shanghai) Co., Ltd (HKG: 2291), a leading medical technology company based in China, has announced that it has obtained a medical device license from the National Medical Products Administration (NMPA) for its RF Lance, a novel disposable radiofrequency atrial septal puncture needle. This product is designed to enhance the precision and safety of atrial septal puncture procedures, which are crucial in various cardiac interventions.
Atrial septal puncture is a critical step in procedures such as atrial fibrillation ablation, left atrial appendage occlusion, and surgeries involving valve replacement or repair for cardiac electrophysiology and structural heart disease treatments. The RF Lance, when used in conjunction with Lepu Scientech’s existing RF generator, assists physicians in performing more accurate and secure puncture procedures. This innovation is particularly beneficial for patients who are candidates for left ventricular intervention therapy through the interatrial septal puncture pathway, potentially elevating the quality of treatment services provided to them.- Flcube.com
